{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:55:02Z","timestamp":1782320102115,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.03.059","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T14:30:46Z","timestamp":1495463446000},"page":"3607-3613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5 mL in adults"],"prefix":"10.1016","volume":"35","author":[{"given":"R.","family":"Konior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brzostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Poellabauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2017.03.059_b0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.idc.2008.03.013","article-title":"Tick-borne encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect Dis Clin N Am"},{"issue":"9627","key":"10.1016\/j.vaccine.2017.03.059_b0010","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"The Lancet"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.03.059_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.vetmic.2009.08.024","article-title":"Zoonotic tick-borne flaviviruses","volume":"140","author":"Dobler","year":"2010","journal-title":"Vet Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.03.059_b0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/erv.12.86","article-title":"Vaccines and vaccination against tick-borne encephalitis","volume":"11","author":"Kollaritsch","year":"2012","journal-title":"Exp Rev Vaccin"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2017.03.059_b0025","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994\u201398: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.059_b0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18\u201367 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Hum Vaccin"},{"issue":"11","key":"10.1016\/j.vaccine.2017.03.059_b0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00365540110027358","article-title":"Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent\/detergent treated, FSME-BULIN S\/D in healthy volunteers","volume":"33","author":"Adner","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.059_b0040","unstructured":"Infectious Diseases and Poisonings in Poland in 2015."},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.059_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1708-8305.2007.00176.x","article-title":"What makes ticks tick? Climate change, ticks, and tick-borne diseases","volume":"15","author":"Suss","year":"2008","journal-title":"J Travel Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.03.059_b0050","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2017.03.059_b0055","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.059_b0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/hv.22766","article-title":"Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)","volume":"9","author":"Zavadska","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2017.03.059_b0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10354-012-0112-1","article-title":"TBE\u2014update on vaccination recommendations for children, adolescents, and adults","volume":"162","author":"Jelinek","year":"2012","journal-title":"Wien Med Wochenschr"},{"issue":"20","key":"10.1016\/j.vaccine.2017.03.059_b0070","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50\u201390 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.03.059_b0075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly \u2013 results from an observational study","volume":"9","author":"J\u00edlkov\u00e1","year":"2009","journal-title":"Exp. Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.059_b0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","article-title":"Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation","volume":"23","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2017.03.059_b0085","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 40","key":"10.1016\/j.vaccine.2017.03.059_b0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijmm.2006.01.030","article-title":"Persistence of antibodies after vaccination against tick-borne encephalitis","volume":"296","author":"Rendi-Wagner","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"50","key":"10.1016\/j.vaccine.2017.03.059_b0095","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.03.059_b0100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2008.11.082","article-title":"Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults","volume":"27","author":"Plentz","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T15:26:42Z","timestamp":1535815602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":20,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17303869"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}